 |
Latest News |
| 14th October 2009 |
| |
Critical Pharmaceuticals Secures £1.5m From Wellcome Trust To Develop hGH Nasal Spray
|
|
| 27th January 2009 |
| |
Global Health Ventures and Critical Sign Memorandum of Understanding for an Anti-Obesity Drug
|
|
| 10th November 2008 |
| |
Critical Pharmaceuticals Raise £650K
|
|
| 1st October 2008 |
| |
Critical Pharmaceuticals Enter Sustained Release hGH Arena
|
|
|
Technology |
| |
Critical Pharmaceuticals uses its supercritical fluid technologies to encapsulate drugs within biodegradable polymers for controlled release applications. In a low temperature, single step, solvent free process we can make injectable microparticles, implants and fibrous materials that constantly release the drug over weeks to months.
|
|
 |
Critical Pharmaceuticals is a biotechnology company with proprietary drug delivery technologies for injectable sustained release and nasal delivery of challenging drugs including proteins and peptides.
read more 
|
| |
Pipeline
Critical Pharmaceuticals are experts in drug delivery and are developing a number of ground breaking products to treat diseases as diverse as growth hormone deficiency and schizophrenia.
See our Pipeline
Partnering
Critical Pharmaceuticals actively partners its drug delivery technologies and candidate drugs with pharmaceutical and biotechnology companies. For more information, or to discuss a specific opportunity, please contact us.
Contact Us
|
|
|
|
